Related Articles
AstraZeneca’s Farxiga fails to get U.S. approval for Type-1 diabetes
(Reuters) – British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a supplement to insulin in adults with a rare-type of the condition. The company said the regulator issued a complete response letter, declining its application for using the drug in […]
Transplanted cells reveal early signs of type 1 diabetes
By the time type 1 diabetes is diagnosed, most of the insulin-producing beta cells have already been destroyed. Now, using an innovative transplantation technique, researchers at Karolinska Institutet and University of Miami Miller School of Medicine have been able to intervene to save the beta cells in mice by discovering early signs of the disease. […]
UM study testing whether Omega 3 and vitamin D can halt progression of Type 1 diabetes
Adult and pediatric Type 1 diabetes patients are being sought for a clinical trial to test if high doses of omega-3 and vitamin D can halt the progression of the disease. The Diabetes Research Institute at the University of Miami Miller School of Medicine is conducting the trial. The Poseidon Trial will study the safety […]